Press Releases | American Food & Beverage Online

Explore more publications!

Press Releases

From Screen to Plate: CJ Foods’ Cuisine. K Brings the Magic of Netflix Hit ‘Bon Appétit, Your Majesty’ to U.S. Kitchens

4 hours ago

From Screen to Plate: CJ Foods’ Cuisine. K Brings the Magic of Netflix Hit ‘Bon Appétit, Your Majesty’ to U.S. Kitchens

GlobeNewswire, Inc.

3 hours ago

Visory Health Ranks Among Top U.S. Prescription Cards Providing Millions of Americans Access to Affordable Medications

GlobeNewswire, Inc.

Ultragenyx Announces U.S. FDA Acceptance of BLA Resubmission for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)

4 hours ago

Ultragenyx Announces U.S. FDA Acceptance of BLA Resubmission for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)

GlobeNewswire, Inc.

Aviation Week by Informa’s Military Aviation, Logistics & Maintenance Symposium will be held in Orlando, April 21-23

an hour ago

Aviation Week by Informa’s Military Aviation, Logistics & Maintenance Symposium will be held in Orlando, April 21-23

EIN Presswire

U Chiang Mai Hotel Honors the Past With Eyes Fixed on a Greener Future

10 hours ago

U Chiang Mai Hotel Honors the Past With Eyes Fixed on a Greener Future

EIN Presswire

Macka B Joins NHS Heart Health Drive & Drops Viral 'Fast Food' Single

8 hours ago

Macka B Joins NHS Heart Health Drive & Drops Viral 'Fast Food' Single

EIN Presswire

10 hours ago

Breaking Brand Licensing Records: License Global Unveils 2026’s Top Agents and Industry Trends

GlobeNewswire, Inc.

Apr. 1, 2026

JenaValve Announces the Start of Commercialization of the Trilogy® Transcatheter Heart Valve System in the United States - the First and Only Transcatheter Device Approved for Symptomatic, Severe Aortic Regurgitation (ssAR)

GlobeNewswire, Inc.

Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis

Apr. 1, 2026

Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis

GlobeNewswire, Inc.

National Arab American Heritage Month Launches April 1, 2026—Arab America Foundation Unites Communities Nationwide

17 hours ago

National Arab American Heritage Month Launches April 1, 2026—Arab America Foundation Unites Communities Nationwide

EIN Presswire

Food Lion Customers Help Provide More Than 13 Million Meals* Through Orange Bag Campaign

Apr. 1, 2026

Food Lion Customers Help Provide More Than 13 Million Meals* Through Orange Bag Campaign

GlobeNewswire, Inc.

Apr. 1, 2026

RenovoRx Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026

GlobeNewswire, Inc.

Apr. 1, 2026

Lapo’s Gains Momentum Launching Nationwide at Target and Whole Foods Market as the No-Alcohol Category Accelerates

EIN Presswire

Meridian Rapid Defense Group Opens New Central U.S. Operations Hub in Hutto, Texas

Mar. 31, 2026

Meridian Rapid Defense Group Opens New Central U.S. Operations Hub in Hutto, Texas

EIN Presswire

Whole Foods, DreamWorks Animation, Chewy are Named to Newsweek’s America’s Most Trustworthy Companies 2026

Apr. 1, 2026

Whole Foods, DreamWorks Animation, Chewy are Named to Newsweek’s America’s Most Trustworthy Companies 2026

GlobeNewswire, Inc.

i-Lumen Scientific Receives FDA Approval of IDE to Initiate U.S. Enrollment in i-SIGHT2 Clinical Study for dry AMD

Mar. 31, 2026

i-Lumen Scientific Receives FDA Approval of IDE to Initiate U.S. Enrollment in i-SIGHT2 Clinical Study for dry AMD

EIN Presswire

Packaging Laminate Market to Reach USD 78.3 Bn by 2035 | Food & Beverage Packaging Surge with Top Companies Amcor, Mondi

Apr. 1, 2026

Packaging Laminate Market to Reach USD 78.3 Bn by 2035 | Food & Beverage Packaging Surge with Top Companies Amcor, Mondi

EIN Presswire

Largest U.S. Event Dedicated to Food Hall Operations Nears Sellout

Mar. 30, 2026

Largest U.S. Event Dedicated to Food Hall Operations Nears Sellout

EIN Presswire

$Serenity Medical Receives U.S. FDA HDE Approval of the River™ Stent - the First Venous Stent Approved for Severe, Refractory Idiopathic Intracranial Hypertension (IIH)$

Mar. 31, 2026

Serenity Medical Receives U.S. FDA HDE Approval of the River™ Stent - the First Venous Stent Approved for Severe, Refractory Idiopathic Intracranial Hypertension (IIH)

GlobeNewswire, Inc.

Mar. 31, 2026

Ambros Therapeutics Announces Notice of Allowance for New U.S. Patent Application Covering Neridronate for Complex Regional Pain Syndrome Type 1

GlobeNewswire, Inc.